Zobrazeno 1 - 10
of 719
pro vyhledávání: '"Ozzard, A."'
Autor:
Ozzard-Low, Patrick
Publikováno v:
Tempo, 2016 Oct 01. 70(278), 45-46.
Externí odkaz:
https://www.jstor.org/stable/26342696
Publikováno v:
In e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 2010 5(1):e14-e17
Autor:
Bower, Mark, Stebbing, Justin, Tuthill, Mark, Campbell, Victoria, Krell, Johnathan, Holmes, Paul, Ozzard, Andrew, Nelson, Mark, Gazzard, Brian, Powles, Tom
Publikováno v:
In Blood 15 April 2008 111(8):3986-3990
Autor:
Wang, J.1, Ozzard, A.1, Nathan, M.1, Atkins, M.1, Nelson, M.1, Gazzard, B.1, Bower, M.1 m.bower@imperial.ac.uk
Publikováno v:
HIV Medicine. Jul2007, Vol. 8 Issue 5, p306-311. 6p. 3 Charts.
Autor:
Ozzard, A. T.
Publikováno v:
The British Medical Journal, 1899 Apr . 1(1999), 964-964.
Externí odkaz:
https://www.jstor.org/stable/20260293
Autor:
Ozzard, A. T.
Publikováno v:
The British Medical Journal, 1895 Dec . 2(1826), 1637-1637.
Externí odkaz:
https://www.jstor.org/stable/20234333
Autor:
Ozzard, A. T.
Publikováno v:
The British Medical Journal, 1896 May 01. 1(1845), 1173-1174.
Externí odkaz:
https://www.jstor.org/stable/20235955
Autor:
Ozzard, A. T.
Publikováno v:
The British Medical Journal, 1909 Sep . 2(2542), 779-780.
Externí odkaz:
https://www.jstor.org/stable/25283543
Publikováno v:
e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism. 5:e14-e17
Summary Background & Aims The manufacture of parenteral nutrition (PN) by pharmacy aseptic units in the UK requires a stated capacity plan. Standard PN formulations maximise manufacturing capacity but reduce the flexibility. The unique nutritional ne
Autor:
Justin Stebbing, Mark Nelson, Johnathan Krell, Brian Gazzard, Mark Bower, Thomas Powles, Mark Tuthill, Victoria Campbell, P Holmes, Andrew Ozzard
Publikováno v:
Blood. 111:3986-3990
The late effects of chemotherapy on immunologic parameters in AIDS-related non-Hodgkin lymphoma (NHL) have not been described. From a cohort of 105 consecutive patients treated with infusional chemotherapy and highly active antiretroviral therapy (HA